Press Releases
Quotient Clinical hosts formulation development and drug delivery seminar series
Quotient Clinical, the Translational Pharmaceutics company, is holding a series of formulation development and drug delivery seminars this June and July. ...
News
7 th Edition of the Innovation Days: The must Partnering event in the Life Sciences
The Innovation Days are a unique international event focused on promoting innovation in the field of Life Sciences . For its 7th edition ,...
News
Mallinckrodt Submits INDA For Synacthen Depot
Company will pursue an indication for the drug in treatment of Duchenne Muscular Dystrophy.Mallinckrodt plc a leading global specialty biopharmaceutical company, announced it has...
Press Releases
Ziarco Pharma Ltd reports positive Phase 2a study results with ZPL-389
Ziarco Pharma Ltd a biopharmaceutical company focusing on the development of novel drugs for the treatment of inflammatory skin disorders, today announces positive, full...
Press Releases
FDA Accepted Charleston Laboratories, Inc. and Daiichi Sankyo’s New Drug Application (NDA) for CL-108
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. announced that the U.S. FDA has accepted for review the New Drug Application (NDA) for CL-108 for...
Press Releases
Teva Pharmaceutical Inc suspends marketing for Zecuity in US
Teva Pharmaceutical Industries, Ltd. announced that it will voluntarily suspend sales, marketing and distribution of ZECUITY® (sumatriptan iontophoretic transdermal system). Teva...
Techno Trends
Merck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif® (interferon beta-1a) Agreement provides Merck with exclusive license to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read